Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia. - Maciocia N; Hoekx M; Acuna C; Wade B; Burley A; Ramanayake S; Nannini F; Wawrzyniecka PA; Karpanasamy T; Schuldt M; Ng S; Ferrari M; et al. (Science translational medicine, 2025)